UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000030584
Receipt number R000034918
Scientific Title MIRACLE (Methotrexate inadequate response patient with Rheumatoid Arthritis treated by Adalimumab in combination with Low-dose Methotrexate) Study
Date of disclosure of the study information 2017/12/27
Last modified on 2023/04/08 11:50:42

No. Disposal Last modified on Item of update
1 Insert 2017/12/27 08:57:54
2 Update 2017/12/27 16:28:32 Date of disclosure of the study information
3 Update 2018/06/27 22:16:54 Classification by specialty
4 Update 2018/06/27 22:22:51 Institutions
5 Update 2018/06/27 22:44:13 Recruitment status
Anticipated trial start date
6 Update 2018/06/27 22:47:14 Secondary IDs
Study ID_1
Org. issuing International ID_1
Org. issuing International ID_1
7 Update 2018/06/27 22:47:14 Secondary IDs
Study ID_1
Org. issuing International ID_1
Org. issuing International ID_1
8 Update 2018/06/28 10:47:39 Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
9 Update 2018/06/29 18:42:50 Institutions
10 Update 2018/08/01 13:30:32 Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
11 Update 2019/01/19 17:23:12 Key inclusion criteria
Key inclusion criteria
12 Update 2019/01/19 17:26:27 Study ID_1
Org. issuing International ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
Org. issuing International ID_2
13 Update 2019/01/19 17:27:48 Recruitment status
14 Update 2019/06/30 09:13:36 Concealment
15 Update 2019/06/30 09:19:58 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email
Institutions
16 Update 2019/06/30 09:25:37 Date of IRB
Last follow-up date
17 Update 2020/01/24 22:01:47 Last follow-up date
18 Update 2020/06/03 19:23:12 Recruitment status
19 Update 2022/06/30 18:28:10 Recruitment status
20 Update 2023/04/08 11:50:43 URL releasing protocol
Publication of results
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures